By: Eric Gascho, NHC Vice President, Policy and Government Affairs Millions of Americans with chronic diseases and disabilities rely on drug therapies to treat their diseases, maintain their quality of […]
Blog
Spotlight: Medical Innovation Action Team
By Katie Soisson, NHC Policy Associate The NHC’s Action Teams are an integral part of the organization’s policy-making process and serve as one of the best ways for member organizations […]
The Benefits of NHC Membership
By: Kelly Garrity, NHC Senior Director, Member Services and Development The National Health Council (NHC) brings together diverse stakeholders within the health community and has a record of successfully influencing […]
A Thousand Little Cuts to the Affordable Care Act
Since last year, Congress and the Administration repeatedly promised to protect health care coverage for Americans with pre-existing conditions. The ACA prohibits insurance companies from turning away people with pre-existing […]
NHC Launches Drug Pricing Blueprint Tracker
Since its release, many of the high-level priorities in the Department of Health and Human Services’ American Patients First drug pricing blueprint have been developed into specific policies, either through […]
Spotlight: Health Care Reform Action Team
By Katie Soisson, NHC Policy Associate The NHC’s Action Teams are an integral part of the organization’s policy-making process and serve as one of the best ways for member organizations […]
Going Back to School with the NHC’s New Educational Series: Increasing Patient-Community Capacity to Engage on Quality of Health Care
Today, the NHC debuted its first online educational series, Increasing Patient-Community Capacity to Engage on Quality of Health Care. The series, comprised of six modules, focuses on why quality is […]
Fighting the Opioid Crisis while Ensuring Access for Those Who Truly Need It
By: Marc Boutin, JD, Chief Executive Officer The National Health Council (NHC) acknowledges the complexity of the opioid crisis in the United States and commends policymakers, health care providers, patient […]
Making the Patient the Center of Comparative Effectiveness
In today’s New York Times, Aaron Carrol writes about the use of comparative effectiveness research to ensure new drugs are safe and effective when compared to other drugs designed to […]
Two Wrongs Don’t Make a Right
By Marc Boutin, JD, NHC Chief Executive Officer Last week, the Centers for Medicare and Medicaid Services (CMS) issued a new policy touted as a way to cut drug spending […]